期刊文献+

1例临床试验受试者损害的赔偿 被引量:5

One case of clinical trial subjects damage compensation
原文传递
导出
摘要 《药物临床试验质量管理规范》第43条:申办者应对参加临床试验的受试者提供保险,对于发生与试验相关的损害或死亡的受试者承担治疗的费用及相应的经济补偿。申办者应当为发生与临床试验相关的伤害或者死亡的受试者承担治疗的费用以及相应的经济补偿,即无过错赔偿原则。诉讼中应采取受试者损害与临床试验的因果关系鉴定,应避免对临床试验机构和申办方都存在较大风险的过错鉴定及赔偿。 Abstract: Article 43 of sponsor shall insure the compensate the medical good clinical practice (GCP) stipulates that the subject participates in clinical trial and shall charges and economic loss for injury or death as- sociated with trial. The injured research subject should be compensated on a no fault basis. It remains necessary for the research subject to demonstrate that his injuries were caused by participation in the trial. If the injured research subject should be compensated on a fault basis, there is heavy risk for both sponsors and hospital.
作者 母双 范贞
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2018年第2期181-183,共3页 The Chinese Journal of Clinical Pharmacology
关键词 临床试验 药物损害 案由 鉴定 无过错赔偿 Key words: clinical trial drug - induced injury cause of action iden-tification no - fault compensation
  • 相关文献

参考文献1

二级参考文献7

共引文献15

同被引文献23

引证文献5

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部